Alphabetical list:
A B C D E F G H I J K L M N O P R S T U V W X Y Q Z 1 2 3 4 5 6 7 8 9
News: December 08, 2009
Tamiflu May Be Inneffective In Fighting Effects Of Flu
December 08, 2009Washington (SmartAboutHealth) - According to a new review, the popular Tamiflu is weak when it comes to the effect it has in preventing effects of the flu, such as the development of pneumonia.
The new review was carried out by researchers in Great Britain, and puts into question the highly-popular flu drug.
Tamiflu was the focus of this update to a review that was published back in 2006, and it looked into a total of 20 published clinical trials on the antiviral drug.
The trials that they examined all looked into the effectiveness of Tamiflu in regards to its ability to prevent, and treat the flu.
The review, was published in the British Medical Journal, and has found that the effectiveness of Tamiflu is certainly something to question.
The researchers had a hard time due to the fact that many of the clinical trials had incomplete data.
This could very well mean that the drug, which governments are spending billions on to stockpile, may not be very effective at all in terms of helping fight the flu and side effects of the flu.
The World Health Organization has stated they will not change their Tamiflu guidelines.
Archive issues: (50)
Archive list: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 [16] 17
October 17, 2011 | Sen. Grassley Seeks FDA Scrutiny of Paxil and Suicide RiskWASHINGTON, June 12, 2008 Senator Chuck Grassley has asked the Food and Drug Administration to carefully scrutinize information it received from drug maker GlaxoSmithKline about the anxiety disorder drug Paxil, based on the contents of a newly available ...
September 21, 2009 | Topical cream studied for erectile dysfunctionScientists from Albert Einstein College of Medicine of Yeshiva University are working on a cream to rub on and treat erectile dysfunction (ED). The cream could prove to be safer than oral medications used to deliver nitric oxide to the cells that improves blood ...
May 21, 2012 | Onyx Rises on Analyst View of Blood Cancer DrugNEW YORK -- Onyx Pharmaceuticals Inc. shares rose Thursday after a Bernstein Research analyst started covering the stock with an "Outperform" rating, saying he thinks the company’s blood cancer drug candidate will reach $1 billion in annual sales by 2016. THE SPARK: Analyst Geoffrey Porges said he thinks that the drug, Kyprolis, will win ...
Related articles:
Treatment - medication (bladder instillations)
DMSO, a wood pulp extract, is the only approved bladder instillation for IC/PBS yet it is much less frequently used in urology clinics. Research studies presented at recent conferences of the American Urological Association by C. Subah Packer have demonstrated that the FDA approved dosage of a 50% solution of DMSO had the potential of creating irreversible muscle contraction. However, a lesser solution of 25% was found to be ...Section: Interstitial cystitis
Chronic prostatitis/chronic pelvic pain syndrome - signs and symptoms
Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is characterised by pelvic or perineal pain without evidence of urinary tract infection, lasting longer than 3 months, as the key symptom. Symptoms may wax and wane. Pain can range from mild discomfort to debilitating. Pain may radiate to back and rectum, making sitting difficult. Dysuria, arthralgia, myalgia, unexplained fatigue, abdominal pain, constant burning pain in the penis, and frequency may all be present. ...Section: Prostatitis
Treatment - pain control
Pain control is usually necessary in the IC/PBS treatment plan. The pain of IC/PBS has been rated equivalent to cancer pain and may lead to central sensitization if untreated. Medication. The use of a variety of traditional pain medications, including opiates and synthetic opioids like tramadol, is often necessary to treat the varying degrees ...Section: Interstitial cystitis